vs
Perella Weinberg Partners（PWP）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
Perella Weinberg Partners的季度营收约是REPLIGEN CORP的1.1倍（$219.2M vs $197.9M），REPLIGEN CORP净利率更高（6.7% vs 6.3%，领先0.4%），REPLIGEN CORP同比增速更快（13.6% vs -2.9%），Perella Weinberg Partners自由现金流更多（$30.5M vs $17.6M），过去两年Perella Weinberg Partners的营收复合增速更高（46.5% vs 14.4%）
佩雷拉温伯格合伙公司是一家聚焦咨询业务的全球投资银行，核心为客户提供战略与财务领域的专业咨询服务，凭借深厚的行业经验和全球化资源网络，为各类企业的重要商业决策提供专业支持。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
PWP vs RGEN — 直观对比
营收规模更大
PWP
是对方的1.1倍
$197.9M
营收增速更快
RGEN
高出16.5%
-2.9%
净利率更高
RGEN
高出0.4%
6.3%
自由现金流更多
PWP
多$12.9M
$17.6M
两年增速更快
PWP
近两年复合增速
14.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $219.2M | $197.9M |
| 净利润 | $13.8M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 8.5% | 9.0% |
| 净利率 | 6.3% | 6.7% |
| 营收同比 | -2.9% | 13.6% |
| 净利润同比 | — | 143.9% |
| 每股收益（稀释后） | $0.11 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PWPRGEN
| Q4 25 | $219.2M | $197.9M | ||
| Q3 25 | $164.6M | $188.8M | ||
| Q2 25 | $155.3M | $182.4M | ||
| Q1 25 | $211.8M | $169.2M | ||
| Q4 24 | $225.7M | $174.1M | ||
| Q3 24 | $278.2M | $154.9M | ||
| Q2 24 | $272.0M | $154.1M | ||
| Q1 24 | $102.1M | $151.3M |
净利润PWPRGEN
| Q4 25 | $13.8M | $13.3M | ||
| Q3 25 | $6.0M | $14.9M | ||
| Q2 25 | $2.7M | $14.9M | ||
| Q1 25 | $17.3M | $5.8M | ||
| Q4 24 | — | $-30.3M | ||
| Q3 24 | $16.4M | $-654.0K | ||
| Q2 24 | $-66.0M | $3.3M | ||
| Q1 24 | $-35.8M | $2.1M |
毛利率PWPRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率PWPRGEN
| Q4 25 | 8.5% | 9.0% | ||
| Q3 25 | 5.4% | 8.9% | ||
| Q2 25 | 5.8% | 7.6% | ||
| Q1 25 | 5.5% | 3.9% | ||
| Q4 24 | — | -17.7% | ||
| Q3 24 | 12.9% | -5.1% | ||
| Q2 24 | -30.2% | 1.0% | ||
| Q1 24 | -52.4% | 1.3% |
净利率PWPRGEN
| Q4 25 | 6.3% | 6.7% | ||
| Q3 25 | 3.6% | 7.9% | ||
| Q2 25 | 1.8% | 8.2% | ||
| Q1 25 | 8.2% | 3.4% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | 5.9% | -0.4% | ||
| Q2 24 | -24.3% | 2.2% | ||
| Q1 24 | -35.1% | 1.4% |
每股收益（稀释后）PWPRGEN
| Q4 25 | $0.11 | $0.24 | ||
| Q3 25 | $0.08 | $0.26 | ||
| Q2 25 | $0.04 | $0.26 | ||
| Q1 25 | $0.24 | $0.10 | ||
| Q4 24 | — | $-0.55 | ||
| Q3 24 | $0.24 | $-0.01 | ||
| Q2 24 | $-1.21 | $0.06 | ||
| Q1 24 | $-0.91 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $255.9M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $-127.4M | $2.1B |
| 总资产 | $797.6M | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资PWPRGEN
| Q4 25 | $255.9M | $767.6M | ||
| Q3 25 | $185.5M | $748.7M | ||
| Q2 25 | $145.0M | $708.9M | ||
| Q1 25 | $111.2M | $697.2M | ||
| Q4 24 | $407.4M | $757.4M | ||
| Q3 24 | $335.1M | $784.0M | ||
| Q2 24 | $185.3M | $809.1M | ||
| Q1 24 | $156.7M | $780.6M |
总债务PWPRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益PWPRGEN
| Q4 25 | $-127.4M | $2.1B | ||
| Q3 25 | $-302.4M | $2.1B | ||
| Q2 25 | $-318.4M | $2.1B | ||
| Q1 25 | $-323.1M | $2.0B | ||
| Q4 24 | $-421.4M | $2.0B | ||
| Q3 24 | $-360.8M | $2.0B | ||
| Q2 24 | $-283.0M | $2.0B | ||
| Q1 24 | $161.9M | $2.0B |
总资产PWPRGEN
| Q4 25 | $797.6M | $2.9B | ||
| Q3 25 | $650.2M | $2.9B | ||
| Q2 25 | $606.7M | $2.9B | ||
| Q1 25 | $570.5M | $2.9B | ||
| Q4 24 | $876.8M | $2.8B | ||
| Q3 24 | $810.9M | $2.8B | ||
| Q2 24 | $645.5M | $2.9B | ||
| Q1 24 | $583.6M | $2.8B |
负债/权益比PWPRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $34.8M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $30.5M | $17.6M |
| 自由现金流率自由现金流/营收 | 13.9% | 8.9% |
| 资本支出强度资本支出/营收 | 2.0% | 4.1% |
| 现金转化率经营现金流/净利润 | 2.52× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $-34.1M | $93.9M |
8季度趋势，按日历期对齐
经营现金流PWPRGEN
| Q4 25 | $34.8M | $25.7M | ||
| Q3 25 | $59.2M | $48.1M | ||
| Q2 25 | $56.1M | $28.6M | ||
| Q1 25 | $-176.5M | $15.0M | ||
| Q4 24 | $223.4M | $39.2M | ||
| Q3 24 | $200.3M | $49.3M | ||
| Q2 24 | $90.0M | $42.2M | ||
| Q1 24 | $-206.3M | $44.7M |
自由现金流PWPRGEN
| Q4 25 | $30.5M | $17.6M | ||
| Q3 25 | $57.6M | $43.4M | ||
| Q2 25 | $55.3M | $21.5M | ||
| Q1 25 | $-177.6M | $11.4M | ||
| Q4 24 | $207.0M | $33.6M | ||
| Q3 24 | $199.3M | $42.3M | ||
| Q2 24 | $83.7M | $37.4M | ||
| Q1 24 | $-214.8M | $36.4M |
自由现金流率PWPRGEN
| Q4 25 | 13.9% | 8.9% | ||
| Q3 25 | 35.0% | 23.0% | ||
| Q2 25 | 35.6% | 11.8% | ||
| Q1 25 | -83.8% | 6.8% | ||
| Q4 24 | 91.7% | 19.3% | ||
| Q3 24 | 71.6% | 27.3% | ||
| Q2 24 | 30.8% | 24.3% | ||
| Q1 24 | -210.3% | 24.0% |
资本支出强度PWPRGEN
| Q4 25 | 2.0% | 4.1% | ||
| Q3 25 | 0.9% | 2.5% | ||
| Q2 25 | 0.5% | 3.9% | ||
| Q1 25 | 0.5% | 2.1% | ||
| Q4 24 | 7.3% | 3.2% | ||
| Q3 24 | 0.4% | 4.5% | ||
| Q2 24 | 2.3% | 3.1% | ||
| Q1 24 | 8.3% | 5.5% |
现金转化率PWPRGEN
| Q4 25 | 2.52× | 1.93× | ||
| Q3 25 | 9.85× | 3.23× | ||
| Q2 25 | 20.50× | 1.92× | ||
| Q1 25 | -10.18× | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | 12.23× | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
